Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07621094 · ClinicalTrials.gov registry record · NA
Intraosseous Antibiotics for Osseointegration
A NA study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07621094 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants.
The verdict
NCT07621094, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn about the characteristics of infection in osseointegration patients. This research study will also study how safe and effective it is to use antibiotics inside the bone.
Interventions
- PROCEDURE intraosseous antibiotic delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-09 |
| Est. Completion | 2031-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07621094
The ClinicalTrials.gov registry entry for NCT07621094 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intraosseous antibiotic delivery is the first listed.
NCT07621094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07621094 about?
NCT07621094 is a clinical study titled "Intraosseous Antibiotics for Osseointegration". The purpose of this research study is to learn about the characteristics of infection in osseointegration patients. This research study will also study how safe and effective it is to use antibiotics inside the bone.
What is the current status of trial NCT07621094?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-09. Estimated completion is 2031-12.
What interventions are being tested in trial NCT07621094?
The interventions under investigation include: intraosseous antibiotic delivery (PROCEDURE).
Who is sponsoring clinical trial NCT07621094?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.